EP3364955
PHARMACEUTICAL FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.10.2016EP published:
20.4.2022EP application number:
16785649.1
EPO information:
European Patent Register
Max expiry date:
10.10.2036
Title in English:
PHARMACEUTICAL FORMULATIONLanguage of the patent:
English
Timeline
Today
11.10.2016EP application
20.4.2022EP Publication
Owner
Name:
RB Health (US) LLCAddress:
399 Interpace Parkway, Parsippany, NJ 07054, US
Inventor
Name:
CAVATUR, RaghuAddress:
Parsippany, NJ 07054, US
Name:
CHEN, KevinAddress:
Parsippany, NJ 07054, US
Name:
KASER, MatthewAddress:
Parsippany, NJ 07054, US
Name:
QIU, HongchunAddress:
Parsippany, NJ 07054, US
Name:
WOODHOUSE, Ernest, JosephAddress:
Slough Berkshire SL1 3UH, GB
Name:
BOROVICKA, JosefAddress:
Slough Berkshire SL1 3UH, GB
Name:
WILKINSON, ElliotAddress:
Slough Berkshire SL1 3UH, GB
Priority
Number:
201562239780 PDate:
9.10.2015Country:
US
Number:
201562239775 PDate:
9.10.2015Country:
US
Classification
Categories:
A61K 9/20, A61K 9/24, A61K 31/09, A61K 31/192, A61K 31/485, A61K 9/22